DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Le Cesne A, Ray-Coquard I, Bui BN, Adenis A, Rios M, Bertucci F. et al.
Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: An open-label multicentre randomised phase 3 trial.
Lancet Oncol 2010;
11: 942-9
We do not assume any responsibility for the contents of the web pages of other providers.